Anavex Life Sciences Corp.

8-K Regulation FD disclosure Aug 3, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Other events Jul 20, 2026 8-K Other events Jun 26, 2026 8-K Delisting notice or listing-rule failure; Other events May 22, 2026 8-K Director or officer change May 15, 2026 8-K Director or officer change May 6, 2026 8-K Other events Mar 25, 2026 8-K Director or officer change; Regulation FD disclosure Feb 25, 2026 10-Q Quarter ended 2025-12-31 Feb 9, 2026 8-K Results of operations (earnings release) Feb 9, 2026 10-K Fiscal year ended 2025-09-30 Nov 25, 2025 8-K Results of operations (earnings release) Nov 25, 2025 8-K Other events Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Entered a material agreement Jul 28, 2025 8-K Director or officer change Jul 3, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 10-Q Quarter ended 2024-12-31 Feb 12, 2025 10-K Fiscal year ended 2024-09-30 Dec 23, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Terminated a material agreement Jul 30, 2024 8-K Shareholder vote results Jun 21, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2023-12-31 Feb 7, 2024 10-K Fiscal year ended 2023-09-30 Nov 27, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Shareholder vote results May 24, 2023 10-Q Quarter ended 2023-03-31 May 9, 2023 8-K Amended charter or bylaws Apr 14, 2023 8-K Regulation FD disclosure Mar 13, 2023 8-K Other events Feb 7, 2023 10-Q Quarter ended 2022-12-31 Feb 7, 2023 10-K/A Fiscal year ended 2022-09-30 Jan 27, 2023 8-K Other events Dec 2, 2022 10-K Fiscal year ended 2022-09-30 Nov 28, 2022 10-Q Quarter ended 2022-06-30 Aug 9, 2022 8-K Shareholder vote results May 27, 2022